These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Atorvastatin promotes human monocyte differentiation toward alternative M2 macrophages through p38 mitogen-activated protein kinase-dependent peroxisome proliferator-activated receptor γ activation. Zhang O; Zhang J Int Immunopharmacol; 2015 May; 26(1):58-64. PubMed ID: 25794645 [TBL] [Abstract][Full Text] [Related]
7. The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction. Hamid T; Ismahil MA; Bansal SS; Patel B; Goel M; White CR; Anantharamaiah GM; Prabhu SD Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429244 [TBL] [Abstract][Full Text] [Related]
8. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Bouhlel MA; Derudas B; Rigamonti E; Dièvart R; Brozek J; Haulon S; Zawadzki C; Jude B; Torpier G; Marx N; Staels B; Chinetti-Gbaguidi G Cell Metab; 2007 Aug; 6(2):137-43. PubMed ID: 17681149 [TBL] [Abstract][Full Text] [Related]
9. Modulation of human monocyte/macrophage activity by tocilizumab, abatacept and etanercept: An in vitro study. Obeng JA; Amoruso A; Camaschella GL; Sola D; Brunelleschi S; Fresu LG Eur J Pharmacol; 2016 Jun; 780():33-7. PubMed ID: 26997366 [TBL] [Abstract][Full Text] [Related]
10. A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages. Amoruso A; Bardelli C; Gunella G; Ribichini F; Brunelleschi S Br J Pharmacol; 2008 May; 154(1):144-52. PubMed ID: 18278062 [TBL] [Abstract][Full Text] [Related]
11. Oxygenized low density lipoprotein down-regulates the TRPV4 protein expression of macrophage through activation of peroxisome proliferator-activated receptor γ. Xue C; Gong J; Guo Y; Yin J; He X; Huang H; Zhou X; Zhao J Minerva Med; 2017 Feb; 108(1):1-12. PubMed ID: 27706112 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Sherman CB; Peterson SJ; Frishman WH Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699 [TBL] [Abstract][Full Text] [Related]
14. Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages. Neri T; Cordazzo C; Carmazzi Y; Petrini S; Balìa C; Stefanelli F; Amoruso A; Brunelleschi S; Breschi MC; Pedrinelli R; Paggiaro P; Celi A Cardiovasc Res; 2012 Jun; 94(3):537-44. PubMed ID: 22425902 [TBL] [Abstract][Full Text] [Related]
15. Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic. Kimmel DW; Dole WP; Cliffel DE Biochem Biophys Res Commun; 2013 Feb; 431(2):181-5. PubMed ID: 23313489 [TBL] [Abstract][Full Text] [Related]
16. Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor gamma. Ding Q; Jin T; Wang Z; Chen Y J Leukoc Biol; 2007 Jun; 81(6):1568-76. PubMed ID: 17369494 [TBL] [Abstract][Full Text] [Related]
17. miR-21-5p regulates mitochondrial respiration and lipid content in H9C2 cells. Nasci VL; Chuppa S; Griswold L; Goodreau KA; Dash RK; Kriegel AJ Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H710-H721. PubMed ID: 30657727 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine. Voloshyna I; Hai O; Littlefield MJ; Carsons S; Reiss AB Eur J Pharmacol; 2013 Jan; 698(1-3):299-309. PubMed ID: 23041272 [TBL] [Abstract][Full Text] [Related]
19. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages. Boss M; Kemmerer M; Brüne B; Namgaladze D Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma expression in monocytes/macrophages from rheumatoid arthritis patients: relation to disease activity and therapy efficacy--a pilot study. Palma A; Sainaghi PP; Amoruso A; Fresu LG; Avanzi G; Pirisi M; Brunelleschi S Rheumatology (Oxford); 2012 Nov; 51(11):1942-52. PubMed ID: 22829690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]